These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 1357741)

  • 1. Treatment of the neuroleptic-nonresponsive schizophrenic patient.
    Meltzer HY
    Schizophr Bull; 1992; 18(3):515-42. PubMed ID: 1357741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients?
    Levin H; Chengappa KN; Kambhampati RK; Mahdavi N; Ganguli R
    J Clin Psychiatry; 1992 Jul; 53(7):248-51. PubMed ID: 1353492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New drugs for the treatment of schizophrenia.
    Meltzer HY
    Psychiatr Clin North Am; 1993 Jun; 16(2):365-85. PubMed ID: 8101373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment-resistant schizophrenia--the role of clozapine.
    Meltzer HY
    Curr Med Res Opin; 1997; 14(1):1-20. PubMed ID: 9524789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine: current status and role in the pharmacotherapy of schizophrenia.
    Remington GJ; Addington D; Collins EJ; Jones BD; Lalonde P; MacCrimmon DJ; MacEwan GW
    Can J Psychiatry; 1996 Apr; 41(3):161-6. PubMed ID: 8722645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia.
    Bitter I; Dossenbach MR; Brook S; Feldman PD; Metcalfe S; Gagiano CA; Füredi J; Bartko G; Janka Z; Banki CM; Kovacs G; Breier A;
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):173-80. PubMed ID: 14687871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suicide in schizophrenia: risk factors and clozapine treatment.
    Meltzer HY
    J Clin Psychiatry; 1998; 59 Suppl 3():15-20. PubMed ID: 9541333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine: efficacy and safety.
    Buchanan RW
    Schizophr Bull; 1995; 21(4):579-91. PubMed ID: 8749886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia.
    Meltzer HY; Bobo WV; Lee MA; Cola P; Jayathilake K
    Psychiatry Res; 2010 May; 177(3):286-93. PubMed ID: 20378185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
    Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind comparative study of clozapine versus chlorpromazine on Chinese patients with treatment-refractory schizophrenia.
    Hong CJ; Chen JY; Chiu HJ; Sim CB
    Int Clin Psychopharmacol; 1997 May; 12(3):123-30. PubMed ID: 9248867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment.
    Meltzer HY; Okayli G
    Am J Psychiatry; 1995 Feb; 152(2):183-90. PubMed ID: 7840350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open trial of clozapine in neuroleptic-resistant childhood-onset schizophrenia.
    Turetz M; Mozes T; Toren P; Chernauzan N; Yoran-Hegesh R; Mester R; Wittenberg N; Tyano S; Weizman A
    Br J Psychiatry; 1997 Jun; 170():507-10. PubMed ID: 9330014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome.
    Lieberman JA; Safferman AZ; Pollack S; Szymanski S; Johns C; Howard A; Kronig M; Bookstein P; Kane JM
    Am J Psychiatry; 1994 Dec; 151(12):1744-52. PubMed ID: 7977880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Practical aspects of drug resistance in schizophrenia].
    Jarema M; Kucińska M
    Psychiatr Pol; 2000; 34(5):721-40. PubMed ID: 11202015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine for the treatment of adolescents with schizophrenia.
    Birmaher B; Baker R; Kapur S; Quintana H; Ganguli R
    J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):160-4. PubMed ID: 1537770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The atypical neuroleptic clozapine (Leponex)--current knowledge and recent clinical aspects].
    Klimke A; Klieser E
    Fortschr Neurol Psychiatr; 1995 May; 63(5):173-93. PubMed ID: 7782019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of a clozapine trial in neuroleptic-resistant schizophrenia.
    Meltzer HY
    Arch Gen Psychiatry; 1989 Jul; 46(7):672. PubMed ID: 2567591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.